Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
American Journal of Public Health
|
October 15, 2020
Public Support for Social Safety-Net Policies for COVID-19 in the United States, April 2020
Colleen L Barry, Hahrie Han, Rachel Presskreischer, et al.
Medical Care
|
September 15, 2025
Defining Pharmacy Access: A Review of Pharmacy-Level Research in the United States
Emeka Elvis Duru, Kenechukwu C Ben-Umeh, Kelly E Anderson, et al.
The American Journal of Managed Care
|
July 19, 2022
Medicare Advantage coverage restrictions for the costliest physician-administered drugs
Kelly E Anderson, G Caleb Alexander, Carolyne Ma, et al.
JAMA
|
November 4, 2024
Pharmacy Closures and Anticonvulsant Medication Prescription Fills
Kelly E Anderson, Maitreyi Sahu, Michael J DiStefano, et al.
JAMA Health Forum
|
August 9, 2024
Macular Degeneration Drug Prescribing Patterns After Step Therapy Introduction in Medicare Advantage
Angela Liu, Kelly E Anderson, Joseph Levy, et al.
The American Journal of Managed Care
|
December 14, 2020
Payment incentives and the use of higher-cost drugs: a retrospective cohort analysis of intravenous iron in the Medicare population
Bryan C Hambley, Kelly E Anderson, Satish P Shanbhag, et al.
JAMA Health Forum
|
August 17, 2022
Physician Network Breadth and Plan Quality Ratings in Medicare Advantage
Aditi P Sen, Mark K Meiselbach, Kelly E Anderson, et al.
Journal of the American Pharmacists Association : Japha
|
October 10, 2025
"The Crux of the Community": A Qualitative Focus Group Study of the Impact of Community Pharmacy Closures in Colorado and Utah
Michael J DiStefano, Nai-Chia Chen, Carl V Asche, et al.
JAMA Network Open
|
April 8, 2021
Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder
Kelly E Anderson, G Caleb Alexander, Lauren Niles, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 14, 2023
Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program
Michael J DiStefano, Antal Zemplenyi, Kelly E Anderson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
American Journal of Public Health
|
October 15, 2020
Public Support for Social Safety-Net Policies for COVID-19 in the United States, April 2020
Colleen L Barry, Hahrie Han, Rachel Presskreischer, et al.
Medical Care
|
September 15, 2025
Defining Pharmacy Access: A Review of Pharmacy-Level Research in the United States
Emeka Elvis Duru, Kenechukwu C Ben-Umeh, Kelly E Anderson, et al.
The American Journal of Managed Care
|
July 19, 2022
Medicare Advantage coverage restrictions for the costliest physician-administered drugs
Kelly E Anderson, G Caleb Alexander, Carolyne Ma, et al.
JAMA
|
November 4, 2024
Pharmacy Closures and Anticonvulsant Medication Prescription Fills
Kelly E Anderson, Maitreyi Sahu, Michael J DiStefano, et al.
JAMA Health Forum
|
August 9, 2024
Macular Degeneration Drug Prescribing Patterns After Step Therapy Introduction in Medicare Advantage
Angela Liu, Kelly E Anderson, Joseph Levy, et al.
The American Journal of Managed Care
|
December 14, 2020
Payment incentives and the use of higher-cost drugs: a retrospective cohort analysis of intravenous iron in the Medicare population
Bryan C Hambley, Kelly E Anderson, Satish P Shanbhag, et al.
JAMA Health Forum
|
August 17, 2022
Physician Network Breadth and Plan Quality Ratings in Medicare Advantage
Aditi P Sen, Mark K Meiselbach, Kelly E Anderson, et al.
Journal of the American Pharmacists Association : Japha
|
October 10, 2025
"The Crux of the Community": A Qualitative Focus Group Study of the Impact of Community Pharmacy Closures in Colorado and Utah
Michael J DiStefano, Nai-Chia Chen, Carl V Asche, et al.
JAMA Network Open
|
April 8, 2021
Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder
Kelly E Anderson, G Caleb Alexander, Lauren Niles, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 14, 2023
Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program
Michael J DiStefano, Antal Zemplenyi, Kelly E Anderson, et al.
Page
of 5